Andrea Kocsis
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficient production of fully active, SARS-CoV-2-priming, wildtype TMPRSS2 ectodomain via co-expression of HAI-2 allows for both auto- and cross-activation mechanisms.
Journal: The Biochemical journal
Published: September 25, 2025
Targeting the complement lectin pathway with a highly specific MASP-2 inhibitor protects against renal ischemia-reperfusion injury.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 14, 2025
Proteomic profiling of serum small extracellular vesicles predicts post-COVID syndrome development.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 03, 2025
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway.
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway.
Journal: International journal of molecular sciences
Published: May 20, 2024
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.
Journal: International journal of molecular sciences
Published: December 21, 2023
Correction: Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.
Journal: The Journal of biological chemistry
Published: December 23, 2022
Proprotein Convertases and the Complement System.
Journal: Frontiers in immunology
Published: May 31, 2022
Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.
Journal: The Journal of biological chemistry
Published: October 06, 2021
Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 26, 2017
MASP-1 and MASP-2 Do Not Activate Pro-Factor D in Resting Human Blood, whereas MASP-3 Is a Potential Activator: Kinetic Analysis Involving Specific MASP-1 and MASP-2 Inhibitors.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 30, 2015
Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 14, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026